HomeELTX • NASDAQ
Elicio Therapeutics Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.74M | 4.83% |
Net income | -11.21M | 5.23% |
Net profit margin | — | — |
Earnings per share | -0.87 | 24.35% |
EBITDA | -10.66M | -4.89% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.35M | 54.82% |
Total assets | 28.14M | 14.97% |
Total liabilities | 19.24M | -1.89% |
Total equity | 8.90M | — |
Shares outstanding | 12.95M | — |
Price to book | 8.46 | — |
Return on assets | -95.31% | — |
Return on capital | -227.15% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.21M | 5.23% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
Previous close
$5.84
Day range
$5.34 - $5.90
Year range
$3.34 - $10.10
Market cap
87.98M USD
Avg Volume
32.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Headquarters
Website
Employees
32
